The University of Chicago Header Logo

Connection

Mitchell C. Posner to Carcinoma, Non-Small-Cell Lung

Back to Details
This is a "connection" page, showing publications Mitchell C. Posner has written about Carcinoma, Non-Small-Cell Lung.
Mitchell C. Posner
Connection Strength
0.115
Carcinoma, Non-Small-Cell Lung
  1. JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non-small Cell Lung Cancers. Mol Cancer Ther. 2018 04; 17(4):732-739.
    View in: PubMed
    Score: 0.085
  2. Phase II study of topotecan in metastatic non-small-cell lung cancer. J Clin Oncol. 1994 Feb; 12(2):347-52.
    View in: PubMed
    Score: 0.016
  3. Combined modality therapy for stage IIIA non-small cell carcinoma of the lung. Eur J Cancer. 1993; 29A(4):511-5.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.